{
  "docId": "019de070-14f8-7659-9020-5924af9296cd",
  "docSlug": "a0353e82ff2da767329aa025539c408b",
  "documentTitle": "Legend Biotech | IPO Presentation Deck | 42 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 42,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a process flow diagram to illustrate the patient journey through the clinical trial.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-14f8-7659-9020-5924af9296cd/15",
  "deckHref": "/decks/019de070-14f8-7659-9020-5924af9296cd",
  "deckJsonHref": "/decks/019de070-14f8-7659-9020-5924af9296cd.json",
  "deckAnchorHref": "/decks/019de070-14f8-7659-9020-5924af9296cd#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.4,
        "x": 0.55,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Screening -> Apheresis -> Bridging Therapy -> Cy/Flu -> JNJ-4528 Infusion -> Post-infusion Assessments -> Follow-up",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a6d8157-a2bd-4fd7-823a-d09ac1b4df3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "NCT03548207; April 20, 2020 data cut-off (efficacy), April 29, 2020 data cut-off (safety)...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70519d0c-cb75-4784-aab8-c1d12f2217ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "list",
      "text": "Primary Objectives: Phase 1b: Characterize safety and confirm Phase 2 dose as informed by the LEGEND-2 study; Phase 2: Evaluate efficacy of JNJ-4528",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "29da1f8d-ac16-4fe1-9469-550cf22b014a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "list",
      "text": "Key Inclusion Criteria: Progressive MM per IMWG criteria; ECOG PS ≤1; Measurable disease; Received ≥3 prior therapies or double refractory; Prior PI, IMiD, anti-CD38 therapy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2db5c5fa-da70-4642-a2d0-e199a1640971",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.05,
        "y": 0.75
      },
      "kind": "list",
      "text": "Administered dose - Ph 1b: Median administered dose was 0.72x10^6 (0.52 – 0.89x10^6) CAR+ viable T cells/kg",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c51cd3c-e7f9-4732-9307-b87ac6ba649e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.05
      },
      "kind": "title",
      "text": "CARTITUDE-1: Phase 1b/2 Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b536947a-084b-4ec0-b2aa-bec765f14506",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "ee899299-39a2-4274-9957-e2a9a86a1c3a",
      "evidence": "The right side of the slide depicts a sequential clinical trial process flow.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}